Acadia Pharmaceuticals buy Citigroup Inc.
Start price
08.05.26
/
50%
€18.83
Target price
08.05.27
€27.29
Performance (%)
30.62%
Price
14.08.26
€24.41
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Acadia Pharmaceuticals has seen massive gains of 30.62%. This prediction currently runs until 08.05.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -3.441% | -3.441% |
| iShares Core DAX® | 0,44 % | 5,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) had its price target lowered by Citigroup Inc. from $33.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.40
07.08.25
07.08.25
-
07.08.26
07.08.26
23.19%
08.08.26
08.08.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.06
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€27.83
09.05.25
09.05.25
8.26%
10.05.25
10.05.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
13.12.23
13.12.23
€35.17
13.12.24
13.12.24
-17.60%
14.12.24
14.12.24

